Effectiveness of seminal plasma in in vitro fertilisation treatment: a systematic review and meta-analysis.


Journal

BJOG : an international journal of obstetrics and gynaecology
ISSN: 1471-0528
Titre abrégé: BJOG
Pays: England
ID NLM: 100935741

Informations de publication

Date de publication:
Jan 2019
Historique:
accepted: 15 10 2017
pubmed: 28 10 2017
medline: 9 3 2019
entrez: 28 10 2017
Statut: ppublish

Résumé

With in vitro fertilization (IVF) techniques, only 20-25% of the transferred embryos lead to a pregnancy. To evaluate the beneficial effects of seminal plasma (SP) or semen applied at the time of oocyte aspiration or embryo transfer. Electronic databases were searched from their inception up to August 2017. We included all randomized controlled trials (RCTs) evaluating the effects of SP or semen in IVF treatment. Trials were considered if women were exposed to any kind of SP or semen (either SP/semen injection or sexual intercourse) around the time of oocyte pickup and embryo transfer. The primary outcome was clinical pregnancy rate (CPR). Eight RCTs on women undergoing IVF (2128 in total) were included in the meta-analysis. Women randomized in the intervention group had a significantly higher CPR compared with controls (30.0 versus 25.1%; RR 1.20; 95% CI, 1.04-1.39). No significant differences were found in the secondary outcomes, including livebirth rate, biochemical pregnancy, miscarriage, multiple pregnancies, and birth weight. The subgroup analyses (four RCTs, 780 participants), including only those RCTs in which prepared undiluted SP was injected just after oocyte pickup, conformed with the overall analysis for the primary outcome (46.3 versus 37.2%; RR 1.23; 95% CI, 1.05-1.45). Because intravaginal or intracervical SP application around the time of oocyte pickup is associated with higher CPR, local application SP may be considered as a potential treatment to improve implantation. SP at the time of oocyte pickup is associated with higher CPR.

Sections du résumé

BACKGROUND BACKGROUND
With in vitro fertilization (IVF) techniques, only 20-25% of the transferred embryos lead to a pregnancy.
OBJECTIVE OBJECTIVE
To evaluate the beneficial effects of seminal plasma (SP) or semen applied at the time of oocyte aspiration or embryo transfer.
SEARCH STRATEGY METHODS
Electronic databases were searched from their inception up to August 2017.
SELECTION CRITERIA METHODS
We included all randomized controlled trials (RCTs) evaluating the effects of SP or semen in IVF treatment. Trials were considered if women were exposed to any kind of SP or semen (either SP/semen injection or sexual intercourse) around the time of oocyte pickup and embryo transfer.
DATA COLLECTION AND ANALYSIS METHODS
The primary outcome was clinical pregnancy rate (CPR).
MAIN RESULTS RESULTS
Eight RCTs on women undergoing IVF (2128 in total) were included in the meta-analysis. Women randomized in the intervention group had a significantly higher CPR compared with controls (30.0 versus 25.1%; RR 1.20; 95% CI, 1.04-1.39). No significant differences were found in the secondary outcomes, including livebirth rate, biochemical pregnancy, miscarriage, multiple pregnancies, and birth weight. The subgroup analyses (four RCTs, 780 participants), including only those RCTs in which prepared undiluted SP was injected just after oocyte pickup, conformed with the overall analysis for the primary outcome (46.3 versus 37.2%; RR 1.23; 95% CI, 1.05-1.45).
CONCLUSION CONCLUSIONS
Because intravaginal or intracervical SP application around the time of oocyte pickup is associated with higher CPR, local application SP may be considered as a potential treatment to improve implantation.
TWEETABLE ABSTRACT CONCLUSIONS
SP at the time of oocyte pickup is associated with higher CPR.

Identifiants

pubmed: 29078039
doi: 10.1111/1471-0528.15004
doi:

Types de publication

Journal Article Meta-Analysis Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

220-225

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2017 Royal College of Obstetricians and Gynaecologists.

Auteurs

G Saccone (G)

Department of Neuroscience, Reproductive Sciences and Dentistry, School of Medicine, University of Naples Federico II, Naples, Italy.

A Di Spiezio Sardo (A)

Department of Public Health, School of Medicine, University of Naples Federico II, Naples, Italy.

A Ciardulli (A)

Department of Obstetrics and Gynecology, University of Rome, Rome, Italy.

C Caissutti (C)

Department of Experimental Clinical and Medical Science, DISM, Clinic of Obstetrics and Gynecology, University of Udine, Udine, Italy.

M Spinelli (M)

Department of Clinical Research, University of Bern, Bern, Switzerland.

D Surbek (D)

Department of Obstetrics and Gynecology, University of Bern, Bern, Switzerland.

M von Wolff (M)

Division of Gynecological Endocrinology and Reproductive Medicine, University Women's Hospital, Bern, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH